12 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
the ability of minority shareholders to elect director candidates;
directors will only be able to be removed for cause;
our amended and restated … of which identifies as female, underrepresented minority or LGBTQ+, by December 31, 2026, unless our board of directors is comprised of five or less
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
of incorporation or amended and restated bylaws provides for cumulative voting, which limits the ability of minority shareholders to elect director candidates … and the second of which identifies as female, underrepresented minority or LGBTQ+, by December 31, 2026, unless our board of directors is comprised of five
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
the ability of minority shareholders to elect director candidates;
directors will only be able to be removed for cause;
our amended and restated articles … one of which identifies as female and the second of which identifies as female, underrepresented minority or LGBTQ+, by December 31, 2026, unless our
S-1
EX-99.4
svj8n
29 Jun 23
IPO registration
4:39pm
S-1
jqhtuy7ob9uhzs5mm
29 Jun 23
IPO registration
4:39pm
DRS/A
tjagb29i
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
m2a6ksnnf lj
2 May 23
Draft registration statement (amended)
12:00am
DRS
mklhfguu
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next